Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel
dc.contributor.author | de Leon, Maria C. B. | |
dc.contributor.author | Bolla, Sridhar | |
dc.contributor.author | Greene, Barbra | |
dc.contributor.author | Hutchinson, Lauren | |
dc.contributor.author | Del Priore, Giuseppe | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2025-04-24T13:20:32Z | |
dc.date.available | 2025-04-24T13:20:32Z | |
dc.date.issued | 2013-05-14 | |
dc.description.abstract | * First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel. * We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | de Leon MC, Bolla S, Greene B, Hutchinson L, Del Priore G. Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel. Gynecol Oncol Case Rep. 2013;5:70-71. Published 2013 May 14. doi:10.1016/j.gynor.2013.05.003 | |
dc.identifier.uri | https://hdl.handle.net/1805/47414 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1016/j.gynor.2013.05.003 | |
dc.relation.journal | Gynecologic Oncology Case Reports | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | PMC | |
dc.subject | Abraxane | |
dc.subject | Docetaxel | |
dc.subject | Hypersensitivity reaction | |
dc.subject | Nab-paclitaxel | |
dc.subject | Paclitaxel | |
dc.subject | Taxol | |
dc.title | Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel | |
dc.type | Article |